11月5日,Stevanato Group S.p.A.(STVN)盘中股价大涨16.77%,引发市场广泛关注。此前该公司公布了最新一季度财报,营收和利润数据表现亮眼,或成为推动股价大涨的主要原因。
据财报显示,Stevanato Group去季度营收达2.79亿美元,同比大幅增长;净利润2220万美元,每股收益0.08美元;毛利润6929万美元,公司经营状况持续向好。虽然目前市盈率较高,但有73%的分析机构给予该股买入评级,体现了外界对公司长期增长前景的信心。
作为为制药和生物技术行业提供包材、输送和诊断解决方案的全球领先供应商,Stevanato Group的产品和服务可满足客户在药物开发、临床测试和商业化等全生命周期的需求。随着疫情好转,医药行业复苏将为该公司带来新的增长动力,推动其订单和营收进一步增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.